Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
161
-
Total 13F shares, excl. options
-
36.8M
-
Shares change
-
-103K
-
Total reported value, excl. options
-
$736M
-
Value change
-
-$581K
-
Put/Call ratio
-
0.43
-
Number of buys
-
77
-
Number of sells
-
-77
-
Price
-
$19.99
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q2 2023
194 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 161 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.8M shares
of 51.1M outstanding shares and own 72.04% of the company stock.
Largest 10 shareholders include BlackRock Inc. (8.27M shares), VANGUARD GROUP INC (4.34M shares), JPMORGAN CHASE & CO (3.7M shares), STATE STREET CORP (2.76M shares), Redmile Group, LLC (2.03M shares), DIMENSIONAL FUND ADVISORS LP (1.39M shares), Aquilo Capital Management, LLC (870K shares), GEODE CAPITAL MANAGEMENT, LLC (814K shares), WS MANAGEMENT LLLP (796K shares), and Sonic GP LLC (743K shares).
This table shows the top 161 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.